With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

McPHERSON, Kan. (KAKE) - Pfizer is laying off dozens of salaried employees at its plant in McPherson, Kansas. According to ...

Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on ...

Guggenheim has earned $172 million from advising Pfizer on nearly $400 billion in acquisitions since 2011. Pfizer’s stock has ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...